Denny Torres, PA
Medical · Lawton, OKNPI 1821083601
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.7% of the total across 107 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 18.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $757, 2.4 times the $315 reported in 2021.
Across 107 payments — averaging $24.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Avadel CNS Pharmaceuticals, LLC$494
- Sanofi$397
- Harmony Biosciences LLC$384
- Jazz Pharmaceuticals Inc.$225
- Optinose US, Inc.$138
- Sanofi-aventis U.S. LLC$135
- plus $868 from 16 others
What the payments were for
- Food & beverage$2,39491%
- Education$2469%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Avadel CNS Pharmaceuticals, LLC | 18 | $494 |
| Sanofi | 15 | $397 |
| Harmony Biosciences LLC | 14 | $384 |
| Jazz Pharmaceuticals Inc. | 6 | $225 |
| Optinose US, Inc. | 7 | $138 |
| Sanofi-aventis U.S. LLC | 3 | $135 |
| Regeneron Healthcare Solutions, Inc. | 8 | $133 |
| GSK | 7 | $128 |
| Greer Laboratories, Inc. | 5 | $99 |
| Alk-abello, Inc | 4 | $96 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $79 |
| Kaleo, Inc. | 4 | $78 |
| Stryker | 2 | $65 |
| Fisher & Paykel Healthcare Inc | 2 | $58 |
| Tactile Systems Technology Inc | 1 | $19 |
| 3b Medical, Inc. | 1 | $19 |
| Olympus America Inc. | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| Preceptis Medical, Inc. | 1 | $16 |
| AstraZeneca | 1 | $13 |
| Medtronic | 1 | $12 |
How this compares
$2,640 in reported general payments places this provider in the 80th percentile of 370 medical providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 60 | $1,977 |
| Clotrimazole | 12 | $139 |
| Methylprednisolone | 16 | $94 |
| Montelukast Sodium | 13 | $85 |
Paid to pharmacies, not to this prescriber.
Other medical in Lawton
- Mebin ThomasOklahoma City$323K
- Kelle ChristiansonMidwest City$117K
- Kristine MurrowOklahoma City$81K
- Matthew DohlmanTulsa$39K
- Katelyn PuryearOklahoma City$22K
- Tara LinvilleTulsa$19K
- Debra OdomTulsa$17K
- Donna BowersTuttle$16K
- Kelly WalworthOklahoma City$15K
- Jere ClaunchOklahoma City$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.